A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)

NCT00422383 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

378

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: rituximab [MabThera/Rituxan]
DRUG: rituximab [MabThera/Rituxan]
DRUG: rituximab [MabThera/Rituxan]

Sponsor

Hoffmann-La Roche